The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. It is located in central Houston in the Texas Medical Center.
MD Anderson was created in 1941 as part of The University of Texas System. The institution is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 49 National Cancer Institute-designated comprehensive cancer centers today.
U.S. News & World Report's "Best Hospitals" survey has ranked MD Anderson the nation's top hospital for cancer care. MD Anderson has been ranked the leading cancer hospital for the past 10 of 11 years. The institution has been named one of the nation's top two hospitals for cancer care every year since the survey began in 1990.
Since 1944, 1.3 million patients have turned to MD Anderson for cancer care.
2017 Patient Care Facts
- MD Anderson cared for close to 137,000 patients — more than 44,000 of whom were new patients
- More than 10,800 participants were enrolled in 1,250-plus clinical trials exploring innovative treatments
- MD Anderson provided uninsured or underinsured Texans more than $179.4 million in uncompensated care
MD Anderson boasts one of the nation's most esteemed faculties.
Among the institution's educators are:
- 8 Health and Medicine Division of the National Academies of Sciences, Engineering and Medicine (formerly the Institute of Medicine) members
- 3 National Academy of Sciences members
- 4 Academy of Arts and Sciences fellows
- 40 American Association for the Advancement of Science fellows
- More than 19,530 employees
- 1,743 faculty members
- Roughly 3,200 onsite and offsite volunteers
Research at MD Anderson
At MD Anderson, important scientific knowledge gained in the laboratory is rapidly translated to clinical care. In FY17, MD Anderson invested more than $844 million in research.
The Moon Shots Program™ continues to dramatically accelerate the pace of converting scientific discoveries into lifesaving advances that reduce cancer deaths. Launched in 2012 with six moon shots, the program has been expanded to 13 multidisciplinary teams of cancer experts collaborating and innovating to stop close to 20 types of cancer that collectively account for 63% of cancer deaths annually.
So far, the Moon Shots Program has received almost $456 million in private philanthropic commitments.
MD Anderson receives millions of dollars in grant funding from the Cancer Prevention Research Institute of Texas (CPRIT) for research, prevention, recruitment and training. In total, the institution has received more than $413 million from CPRIT since its formation.
FY 2017 by the numbers:
- 7,091 trainees, including scientists, nurses and allied health professionals
- 1,755 clinical residents and fellows
- 397 undergraduate and graduate students at the School of Health Professions
- 405 graduate students at the Graduate School of Biomedical Sciences
- Close to 1,775 research trainees